- Home
- GLMD vs EKSO Comparison
GLMD vs EKSO Comparison
Compare GLMD & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- EKSO
- Stock Information
- Founded
- GLMD 2000
- EKSO 2005
- Country
- GLMD Israel
- EKSO United States
- Employees
- GLMD N/A
- EKSO N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- GLMD Health Care
- EKSO Health Care
- Exchange
- GLMD Nasdaq
- EKSO Nasdaq
- Market Cap
- GLMD 7.5M
- EKSO 7.7M
- IPO Year
- GLMD 2014
- EKSO N/A
- Fundamental
- Price
- GLMD $1.48
- EKSO $3.95
- Analyst Decision
- GLMD Hold
- EKSO Strong Buy
- Analyst Count
- GLMD 1
- EKSO 2
- Target Price
- GLMD N/A
- EKSO $34.75
- AVG Volume (30 Days)
- GLMD 213.6K
- EKSO 38.8K
- Earning Date
- GLMD 11-13-2025
- EKSO 10-27-2025
- Dividend Yield
- GLMD N/A
- EKSO N/A
- EPS Growth
- GLMD N/A
- EKSO N/A
- EPS
- GLMD N/A
- EKSO N/A
- Revenue
- GLMD N/A
- EKSO $14,651,000.00
- Revenue This Year
- GLMD N/A
- EKSO N/A
- Revenue Next Year
- GLMD N/A
- EKSO $49.96
- P/E Ratio
- GLMD N/A
- EKSO N/A
- Revenue Growth
- GLMD N/A
- EKSO N/A
- 52 Week Low
- GLMD $1.15
- EKSO $2.73
- 52 Week High
- GLMD $23.80
- EKSO $19.20
- Technical
- Relative Strength Index (RSI)
- GLMD 51.13
- EKSO 54.95
- Support Level
- GLMD $1.33
- EKSO $3.81
- Resistance Level
- GLMD $1.60
- EKSO $4.02
- Average True Range (ATR)
- GLMD 0.10
- EKSO 0.26
- MACD
- GLMD 0.03
- EKSO 0.00
- Stochastic Oscillator
- GLMD 66.67
- EKSO 60.00
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.